Swedish Orphan Drug Maker Moves into the U.S.

Ready or not, here comes Swedish Orphan Biovitrum AB (STO: SOBI). The company recently paid $1.5 billion to AstraZeneca (NYSE: AZN) in a double-sided deal. First, it’s acquiring the perpetual U.S. rights to Synagis (palivizumab), which prevents serious lower respiratory tract infections (LRTI) caused by FSV in high-risk infants. The other side of the deal […]

 

athenahealth Finds a Buyer and a Merger Partner

Only two weeks into the month of November 2018, and already the deal value is higher than all of October. Through November 14, nearly $9.8 billion has been spent, but that’s largely because of a single deal, and one that’s been long in the works. After a lengthy bidding process, athenahealth (NASDAQ: ATHN) was acquired […]

 

It’s a Glass Half-Something View of Healthcare M&A

If you only saw one story regarding Capital One Healthcare‘s (NYSE: COF) recent industry survey, then you only saw one view of where the respondents think the industry is heading. Every year, Capital One surveys a group of healthcare services executives and private equity firms on their opinions regarding the industry’s business performance, likely merger […]

 

ZT Corporate Scoops up Six Freestanding Emergency Centers

ZT Corporate, a Houston-based private equity firm formerly known as ZT Wealth, won its stalking-horse bid to acquire six freestanding emergency centers in the Houston area, operating under the Neighbors Emergency Center brand. Founded in 1997, the firm owns and manages Altus Health, whose operations include a surgical hospital, cancer centers and three freestanding emergency […]

 

Health Care M&A Deals, Week Ending November 9, 2018

The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular […]

Pacific Biosciences Gives Illumina a Long-Read View

Only one week into November and deal value stands at $2.5 billion. Not a bad start, given that October’s full deal value totals $9.4 billion. At least 60% of November’s spending comes from one deal, Illumina‘s (NASDAQ: ILMN) acquisition of Pacific Biosciences (NASDAQ: PACB) for $1.2 billion. The all-cash price consists of $8.00 per share for Pacific […]

ResMed Pays Big for MatrixCare

It’s a frothy, frothy market in most areas of health care, and the digital health space just got frothier. ResMed Inc. (NYSE: RMD), which makes medical equipment to monitor respiratory disorders, announced it paid $750 million for MatrixCare, a portfolio company of OMERS Private Equity. Right up front, ResMed touted the 25x price/EBITDA multiple, based […]

October 2018 Healthcare Deal Spending Breaks Even

Spending on healthcare deals in the month of October didn’t match the surge in deal volume (see separate post). At $9.4 billion, October 2018 posted a slight 4% gain over September, but was 25% lower than the $12.6 billion spent in October 2017. Of course, we can only go by disclosed prices, and several transactions […]

Fourth Quarter 2018 Blasts Off with Heavy Deal Volume

Healthcare transactions kicked into high gear in October, with preliminary data showing a monthly total of 176 deals, the highest monthly tally reported this year. It bests September’s 144 deals by 22%, and the year-ago volume of 151 deals by 17%. Eight of the 13 sectors saw solid gains compared with October 2017 results. The […]

Health Care M&A Deals, Week Ending November 2, 2018

The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular […]